Enhancing efficiency in genomic research with a single-workflow solution
Thermo Fisher Scientific has unveiled the Applied Biosystems™ MagMAX™ Sequential DNA/RNA Kit, a revolutionary product designed to simplify DNA and RNA isolation for comprehensive genomic analysis. This all-in-one kit integrates DNA and RNA extraction into a single streamlined workflow, addressing the growing demands of genomic research in hematological malignancies such as leukemia, lymphoma, and myeloma.
The MagMAX Sequential DNA/RNA Kit accommodates up to 15,000 white blood cells per microliter without requiring red blood cell lysis, enabling labs to process complex samples with ease. Researchers benefit from higher lab productivity and reduced costs while preserving sample integrity.
Key Features of the MagMAX Sequential DNA/RNA Kit
- Integrated Workflow: Combines DNA and RNA isolation into a single process.
- High-Capacity Processing: Handles up to 15,000 white blood cells per microliter.
- Separate DNA and RNA Eluates: Eliminates additional steps, such as manual RNase treatment.
- Scalable Input Volumes: Offers flexibility for various research needs.
- Compact Packaging: Saves storage space in busy lab environments.
The MagMAX kit is a valuable tool for specialty labs, academic medical centers, and pharmaceutical companies conducting genomic research and clinical trials. By streamlining nucleic acid isolation, it supports faster and more reliable results in critical studies.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release, visit Thermo Fisher Scientific's website